The results revealed that oral intake of PS-NPs exacerbated metabolic disorders in mice on a HFD, manifesting as suppressed energy expenditure, increased fat mass and liver steatosis, decreased insulin sensitivity, disrupted glucose homeostasis, and reduced cold tolerance compared to the control group. This evidence concerns the gene INS and Other metabolic disease.